Mode
Text Size
Log in / Sign up

No risk score outperformed WHO IMCI criteria for predicting pediatric pneumonia mortalityRisk Scores Do Not Outperform Standard Care for Pneumonia

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that no validated risk score outperformed standard WHO IMCI criteria for predicting pediatric pneumonia mortality.

This secondary analysis of a randomized controlled trial evaluated the performance of five published risk scores compared to WHO Integrated Management of Childhood Illness (IMCI) criteria and danger signs. The study included 1010 children without HIV hospitalized with pneumonia across Mozambique, South Africa, Uganda, Zambia, and Zimbabwe.

The primary outcomes were in-hospital mortality, 28-day mortality, and 28-day readmission or death. For in-hospital mortality (18 deaths; 1.8%), risk scores achieved an AUC of 0.75-0.84. For in-hospital plus 7-day mortality (22 deaths; 2.2%), the AUC was also 0.75-0.84. For 28-day readmission or death (63 events; 6.2%), the AUC was lower, at 0.54-0.58.

Safety and tolerability data were not reported as this was a secondary analysis of an existing trial. A primary limitation noted is that the small number of mortality events limits precision, meaning modest differences between models cannot be excluded. Clinical utility is currently limited because no risk score consistently outperformed simple clinical criteria for predicting outcomes.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in the management of pediatric pneumonia by evaluating predictive tools rather than diagnostic interventions. While rapid diagnostic panels were previously shown to improve targeted antibiotic adjustments, this study indicates that complex risk scores do not provide superior predictive value over standard WHO IMCI-based clinical assessments for mortality.

Researchers analyzed data from a large study involving 1,010 children hospitalized with pneumonia across five African countries. The goal was to see if using advanced mathematical risk scores could better predict which children might face serious complications compared to the standard clinical tools currently used by doctors.

The results showed that none of the complex risk scores performed better than the standard WHO Integrated Management of Childhood Illness criteria. While some scores were able to identify patients at risk for death or readmission, they did not provide a significant advantage over the simple clinical signs already used in hospitals.

Because there were relatively few deaths during the study period, it is hard to say with absolute certainty how well these tools perform. For now, the findings suggest that standard clinical assessments remain a reliable way to manage pneumonia cases in children. Patients and families can rely on the current standards of care for monitoring and treatment.

What this means for you:
Standard clinical tools are currently as effective as complex risk scores for predicting pneumonia outcomes in children.

Common questions

Are complex risk scores better than current methods for treating childhood pneumonia?

The study found that no risk score consistently outperformed the standard WHO Integrated Management of Childhood Illness criteria. While some scores were tested to see if they could better predict mortality or readmission, they did not show a clear advantage over the simple clinical signs doctors already use to manage patients.

How many children were included in this study?

The analysis included 1,010 children who were hospitalized with pneumonia across five countries: Mozambique, South Africa, Uganda, Zambia, and Zimbabwe. This large group helped researchers compare different ways of predicting patient outcomes.

What did the study find regarding readmission or death?

The study looked at 28-day readmission or death, which occurred in 63 cases out of 1,010. However, the risk scores used to predict these events were not found to be more effective than standard clinical assessments.

Study Details

Study typeRct
Sample sizen = 1,010
EvidenceLevel 2
PublishedJun 2026
View Original Abstract ↓
Background Risk stratification tools for childhood pneumonia have been proposed to improve identification of children at highest risk of death, particularly in low-resource settings. However, their added value over the WHO Integrated Management of Childhood Illness (IMCI) criteria and danger signs remains uncertain. Methods We conducted a secondary analysis of a multi-country randomised controlled trial of children without HIV hospitalised with pneumonia in Mozambique, South Africa, Uganda, Zambia, and Zimbabwe. We evaluated the performance of five published risk scores alongside WHO IMCI severity classification and danger signs. Discrimination for (1) in-hospital mortality, (2) 28-day mortality, and (3) 28-day readmission or death was assessed using area under the receiver operating characteristic curve (AUC). Comparative performance and clinical utility were examined. Results Of the 1010 participants, 18 (1.8%) died in hospital, 22 (2.2%) died in hospital or in the 7 days post-discharge, and 63 (6.2%) died or were readmitted by day 28. Univariate case-fatality rates were highest for variables associated with malnutrition, convulsions, and hypoxaemia. All risk scores demonstrated moderate discrimination for in-hospital and in-hospital+7-day mortality (AUC range approximately 0.75-0.84), with no meaningful differences between models, and performed similarly to the WHO danger signs and IMCI severity classification. In contrast, all approaches performed poorly in predicting 28-day readmission or death (AUC approximately 0.54-0.58). No risk score consistently outperformed simple clinical criteria. Conclusions In this multi-country dataset, we found no evidence that published paediatric pneumonia risk scores meaningfully outperform WHO IMCI-based clinical assessment for predicting mortality. The relatively small number of mortality events limits precision, and modest differences cannot be excluded. These findings suggest that, in low-resource settings, strengthening implementation of existing WHO clinical criteria may be more effective than adopting more complex prediction tools.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.